Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$7.99 -0.13 (-1.66%)
As of: Oct 2, 2026 · 11:49 AM EDT

Biocryst Pharmaceuticals (BCRX) Accumulated Expenses (2010 - 2026)

Updated

Biocryst Pharmaceuticals (BCRX) reported Accumulated Expenses of $121.9 million for Q2 2026, up 13.8% from $107.11 million a year earlier and up 2.1% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025, Biocryst Pharmaceuticals posted Accumulated Expenses of $126.41 million, up 11.6% from FY2024.

  • Accumulated Expenses has increased for nine consecutive years, with a five-year compound annual growth rate of 30.1% (FY2020 to FY2025).
  • By year, Accumulated Expenses came in at $113.29 million in FY2024 (+10.1%), $102.88 million in FY2023 (+17.5%), $87.57 million in FY2022 (+20.5%) and $72.67 million in FY2021 (+114.1%).
  • Five-year quarterly Accumulated Expenses spans a low of $56.31 million in Q3 2021 and a high of $126.41 million in Q4 2025.
  • Year over year, Accumulated Expenses has now increased in each of the last 12 quarters, with growth averaging 18.7% over the last eight quarters.
  • The high point for year-over-year Accumulated Expenses in five years was Q4 2021 (growth of 114.1%); the low point was Q2 2023 (a decline of 5.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $119.4 million (Q1 2026), $126.41 million (Q4 2025) and $118.78 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Biocryst Pharmaceuticals 2.13 Bn 1.05 Bn 214.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121.90 Mn
Mar 31, 2026 119.40 Mn
Dec 31, 2025 126.41 Mn
Sep 30, 2025 118.78 Mn
Jun 30, 2025 107.11 Mn
Mar 31, 2025 92.64 Mn
Dec 31, 2024 113.29 Mn
Sep 30, 2024 104.20 Mn
Jun 30, 2024 89.60 Mn
Mar 31, 2024 79.25 Mn
Dec 31, 2023 102.88 Mn
Sep 30, 2023 77.39 Mn
Jun 30, 2023 75.30 Mn
Mar 31, 2023 75.21 Mn
Dec 31, 2022 87.57 Mn
Sep 30, 2022 69.27 Mn
Jun 30, 2022 79.71 Mn
Mar 31, 2022 63.58 Mn
Dec 31, 2021 72.67 Mn
Sep 30, 2021 56.31 Mn
API Access

Biocryst Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BCRX&period=max&api_key=YOUR_API_KEY